Notice of GM

Summary by AI BETAClose X

Scancell Holdings plc has announced a circular and notice of a General Meeting to approve a proposed share consolidation, which will see every 10 existing ordinary shares of £0.001 each consolidated into 1 consolidated ordinary share of £0.01 each, impacting its 1,212,230,683 issued shares as of September 30, 2026. This consolidation is intended to facilitate a proposed merger with Neuphoria Therapeutics Inc. and a Nasdaq listing, with the General Meeting scheduled for October 20, 2026, and the share consolidation expected to become effective on October 21, 2026.

Disclaimer*

UK 100

Latest directors dealings